EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Guiding pluripotent stem cell therapies past the immune system

Hannah A Pizzato iD, Deepta Bhattacharya iD

Stem Cells Translational Medicine · 20.07.2026 · 15 (8)

DOI: 10.1093/stcltm/szag051 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 05.08.2026. Verfasst von Hannah A Pizzato und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Molecular and Immunological Therapies, University of Arizona, Tucson, AZ 85724, United States. Hauptthemen laut MEDLINE: Pluripotent Stem Cells, Diabetes Mellitus, Type 1, Stem Cell Transplantation, Graft Rejection. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pluripotent stem cell (PSC)-based therapies hold the potential to unlock cures for numerous diseases, including, but not limited to, Parkinson’s disease, macular degeneration, heart failure, type 1 diabetes, and cancer. Yet as protocols to differentiate PSCs into therapeutically useful cell types have progressed rapidly, immunological rejection remains a major barrier that may limit the widespread use of such PSC-based therapies. In recent years, strategies to genetically modify PSCs to prevent immunological rejection of the downstream cell product have become a point of emphasis. Here, we provide an immunological perspective on these strategies, discussing the breadth of rejection mechanisms that have been uncovered through decades of research and the relative simplicity of designing PSC immune evasion strategies to circumvent these mechanisms. We focus in particular on how these strategies apply to the treatment of type 1 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pluripotent Stem CellsDiabetes Mellitus, Type 1Stem Cell TransplantationGraft RejectionImmune SystemHumansAnimals

Stichwörter der Autor:innen

cell transplantationgraft rejectionpluripotent stem cellsregenerative medicinetransplantation immunology

Autor:innen und Institutionen

  • Center for Advanced Molecular and Immunological Therapies, University of Arizona, Tucson, AZ 85724, United States.
  • Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ 85724, United States.
  • Department of Surgery, University of Arizona College of Medicine, Tucson, AZ 85724, United States.
  • BIO5 Institute, University of Arizona, Tucson, AZ 85724, United States.
  • University of Arizona Cancer Center, Tucson, AZ 85724, United States.

ORCID-Profile: Hannah A Pizzato, Deepta Bhattacharya

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Pizzato, H. A., & Bhattacharya, D. (2026). Guiding pluripotent stem cell therapies past the immune system. Stem Cells Translational Medicine, 15(8). https://doi.org/10.1093/stcltm/szag051

Vancouver

Pizzato HA, Bhattacharya D. Guiding pluripotent stem cell therapies past the immune system. Stem Cells Translational Medicine. 2026;15(8). doi:10.1093/stcltm/szag051

BibTeX
@article{Pizzato2026,
  author = {Pizzato, Hannah A and Bhattacharya, Deepta},
  title = {Guiding pluripotent stem cell therapies past the immune system},
  journal = {Stem Cells Translational Medicine},
  year = {2026},
  volume = {15},
  number = {8},
  doi = {10.1093/stcltm/szag051}
}
Kostenlos starten →